AI-generated analysis. Always verify with the original filing.
AIAI Holdings Corporation is a newly formed Delaware corporation pursuing a direct listing on Nasdaq under ticker 'AIAI' to enable resale of 69,483,430 shares of Class A common stock by registered stockholders, with no proceeds to the company. The company acquires AI-adjacent portfolio companies—CCCI (civil construction), Constellation (blockchain/digital evidence), MediGuide (healthcare/telehealth), AIR (AI research), Vanguard (healthcare consulting), and Bond Street (document services)—immediately prior to listing effectiveness. It licenses proprietary M42 AI technology (psychometric, math/science-based) exclusively for its field of use: building an AI ecosystem to scale companies across sectors like construction, healthcare, and defense. Pro forma 2025 financials show $272M revenue (primarily from CCCI's $253M services) and ($160M) net loss, driven by amortization of $889M intangibles and $131M license asset. Investment thesis: Accelerate AI integration via acquisitions (4-6 months vs. industry 24 months), targeting $1.5B EBITDA pipeline in high-potential verticals amid $638B global AI market (18.6% CAGR to 2030). Founder John Rochon controls 50.1% voting post-listing via Class B shares. Risks include acquisition execution, AI implementation delays, and reliance on M42 license.
Shares Offered
560,000,000
to retire outstanding CCCI indebtedness of $24.2 million which existed as of the Closing Date. The remaining proceeds will be utilized
Shares Offered
69,483,430
Share Type
Class A Common Stock
Exchange
Nasdaq Global Market
Ticker
AIAI
Use of Proceeds: No proceeds to company; resale by stockholders
Holding company acquiring AI-adjacent firms to integrate licensed M42 AI for operational scaling across construction, healthcare, defense, blockchain.